Healthcare-focused private equity fund Tata Capital Healthcare Fund II (TCHF II) announced that it has invested an amount of USD 20 million in Orbicular Pharmaceutical Technologies Private Limited ...

Orbicular Pharmaceutical Technologies has agreed to resolve its patent fight with Theravance Biopharma (NASDAQ:TBPH) and Viatris (NASDAQ:VTRS) unit, Mylan, over the respiratory disorder therapy ...

Tata Capital Healthcare Fund (TCHF) a healthcare-focused private equity fund, has invested approximately $20 million in Orbicular Pharmaceutical Technologies Private Limited for an undisclosed ...

Alembic Pharmaceuticals Ltd on Tuesday said it has acquired 100 per cent stake in Aleor Dermaceuticals Ltd from its joint venture (JV) partner Orbicular Pharmaceutical Technologies Pvt Ltd to ...

Orbicular, a specialty pharmaceutical company focused on research and product development, will use its expertise in drug delivery and formulation to develop nasal sprays for global markets.